Literature DB >> 15551107

Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets.

Friedrich C Luft1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15551107     DOI： 10.1007/s00109-004-0609-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN： 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  10 in total

Review 1.  Role of matrix metalloproteinases in vascular remodeling.

Authors:  Masafumi Kuzuya; Akihisa Iguchi
Journal:  J Atheroscler Thromb       Date:  2003       Impact factor: 4.928

Review 2.  Matrix metalloproteinases: pathways of induction by bioactive molecules.

Authors:  Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 3.  Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling.

Authors:  Alex J Chase; Andrew C Newby
Journal:  J Vasc Res       Date:  2003-07-29       Impact factor: 1.934

4.  Green tea catechins inhibit the cultured smooth muscle cell invasion through the basement barrier.

Authors:  Keiko Maeda; Masafumi Kuzuya; Xian Wu Cheng; Toshinobu Asai; Shigeru Kanda; Norika Tamaya-Mori; Takeshi Sasaki; Tami Shibata; Akihisa Iguchi
Journal:  Atherosclerosis       Date:  2003-01       Impact factor: 5.162

5.  Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.

Authors:  Jens Fielitz; Manuela Leuschner; Heinz Renee Zurbrügg; Britta Hannack; Reinhard Pregla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  J Mol Med (Berl)       Date:  2004-11-19       Impact factor: 4.599

Review 6.  Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms.

Authors:  Nikolaos P Kadoglou; Christos D Liapis
Journal:  Curr Med Res Opin       Date:  2004-04       Impact factor: 2.580

Review 7.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

8.  Evidence for an altered balance between matrix metalloproteinase-9 and its inhibitors in calcific aortic stenosis.

Authors:  Jari Satta; Jani Oiva; Tuula Salo; Heidi Eriksen; Pasi Ohtonen; Fausto Biancari; Tatu S Juvonen; Ylermi Soini
Journal:  Ann Thorac Surg       Date:  2003-09       Impact factor: 4.330

9.  Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis.

Authors:  Jens J Kaden; Carl-Erik Dempfle; Rainer Grobholz; Hanh-Thai Tran; Refika Kiliç; Aslihan Sarikoç; Martina Brueckmann; Christian Vahl; Siegfried Hagl; Karl K Haase; Martin Borggrefe
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Myocardial collagen turnover in hypertrophic cardiomyopathy.

Authors:  Raffaella Lombardi; Sandro Betocchi; Maria Angela Losi; Carlo Gabriele Tocchetti; Mariano Aversa; Marianna Miranda; Gianluigi D'Alessandro; Alessandra Cacace; Quirino Ciampi; Massimo Chiariello
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690
  10 in total
  3 in total

1.  QM/MM Studies of the Matrix Metalloproteinase 2 (MMP2) Inhibition Mechanism of (S)-SB-3CT and its Oxirane Analogue.

Authors:  Jia Zhou; Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Chem Theory Comput       Date:  2010-11-09       Impact factor: 6.006

2.  Matrix metalloproteinase 2 inhibition: combined quantum mechanics and molecular mechanics studies of the inhibition mechanism of (4-phenoxyphenylsulfonyl)methylthiirane and its oxirane analogue.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Thom Vreven; Shahriar Mobashery; H Bernhard Schlegel
Journal:  Biochemistry       Date:  2009-10-20       Impact factor: 3.162

3.  Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.

Authors:  Peng Tao; Jed F Fisher; Qicun Shi; Shahriar Mobashery; H Bernhard Schlegel
Journal:  J Phys Chem B       Date:  2010-01-21       Impact factor: 2.991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.